Hennion & Walsh Asset Management, Inc. Becton Dickinson & CO Transaction History

Hennion & Walsh Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$238.39 - $265.32 $81,052 - $90,208	-340 Reduced 15.08%	1,914 $505,000
Q1 2023 Apr 20, 2023	SELL	$229.71 - $259.35 $12,174 - $13,745	-53 Reduced 2.3%	2,254 $558,000
Q4 2022 Jan 12, 2023	SELL	$218.29 - $256.91 $16,590 - $19,525	-76 Reduced 3.19%	2,307 $587,000
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $6,327 - $32,764	-124 Reduced 4.95%	2,383 $531,000
Q2 2022 Jul 19, 2022	SELL	$234.74 - $275.42 $8,215 - $9,639	-35 Reduced 1.38%	2,507 $618,000
Q1 2022 Apr 26, 2022	BUY	$243.64 - $270.48 $26,069 - $28,941	107 Added 4.39%	2,542 $676,000
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $206,151 - $224,842	896 Added 58.22%	2,435 $612,000
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $107,051 - $117,976	-460 Reduced 23.01%	1,539 $378,000
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $503,919 - $551,420	-2,166 Reduced 52.0%	1,999 $486,000
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $966,654 - $1.07 Million	4,165 New	4,165 $1.01 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.